News
Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383:1436-1446. McMurray JJV, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med.
New Delhi: AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the trial of Baxdrostat Tablets ...
5mon
HealthDay on MSNDiabetes Remission Increased With Dapagliflozin Plus Calorie Restriction - MSNMONDAY, Jan. 27, 2025 (HealthDay News) -- For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus ...
When dapagliflozin and empagliflozin were compared, the risk of MI/stroke was similar, but dapagliflozin was associated with a higher risk of HF hospitalization (HR 1.19; 95% CI 1.02-1.39).
AstraZeneca’s Farxiga (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycaemic control in paediatric patients with type-2 diabetes ... The primary endpoint ...
Dapagliflozin was approved by FDA for children and adolescents aged 10 years and older with type 2 diabetes. The SGLT2 inhibitor lowered HbA1c by 0.62 percentage points at 26 weeks in the T2NOW trial.
The efficacy analysis reports data on patients who were randomised to three treatment arms evaluating 1) high-dose combination of zibotentan (1.5 mg) and dapagliflozin (10 mg), 2) low-dose combination ...
Dapagliflozin 10 mg: -3.4 mmHg (90% CI -5.8 to -1.0) The secondary endpoint of change in eGFR took a dive within the first week of treatment, ... The trial was funded by AstraZeneca.
AstraZeneca Pharma India on Monday said it has received approval for extended indication from the Drugs Controller General of India for Dapagliflozin 10 mg tablets. View in App The receipt of this ...
AstraZeneca Pharma India on Monday said it has received approval for extended indication from the Drugs Controller General of India for Dapagliflozin 10 mg tablets. The company has received permission ...
New Delhi: AstraZeneca Pharma India on Monday said it has received approval for extended indication from the Drugs Controller General of India for Dapagliflozin 10 mg tablets. The company has received ...
2.1 Dapagliflozin (Forxiga, AstraZeneca) ... 2.4 The list price of 10 mg dapagliflozin is £36.59 per 28‑tablet pack (excluding VAT; BNF online accessed April 2023). The annual treatment cost is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results